Article Information
PubMed
Published By
Print ISSN
Online ISSN
History
- Accepted for publication January 4, 2019
- Published online August 1, 2019.
Article Versions
- Latest version (January 15, 2019 - 04:00).
- Latest version (January 15, 2019 - 11:15).
- Latest version (May 15, 2019 - 04:00).
- You are viewing the most recent version of this article.
Copyright & Usage
© 2019 Free online via JRheum Full Release option
Author Information
- Charles Peterfy⇑,
- Julie DiCarlo,
- Paul Emery,
- Mark C. Genovese,
- Edward C. Keystone,
- Peter C. Taylor,
- Doug E. Schlichting,
- Scott D. Beattie,
- Monica Luchi and
- William Macias
- From Spire Sciences Inc., Boca Raton, Florida; Division of Immunology and Rheumatology, Stanford University, Stanford, California; Eli Lilly and Co., Indianapolis, Indiana; Incyte Corporation, Wilmington, Delaware, USA; The Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds; Botnar Research Centre, University of Oxford, Oxford, UK; Department of Rheumatology, University of Toronto, Toronto, Ontario, Canada.
- C. Peterfy, MD, PhD, Spire Sciences Inc.; J. DiCarlo, PhD, Spire Sciences Inc.; P. Emery, MD, FRCP, The Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds; M.C. Genovese, MD, Division of Immunology and Rheumatology, Stanford University; E.C. Keystone, MD, FRCP, Department of Rheumatology, University of Toronto; P.C. Taylor, MA, PhD, FRCP, Botnar Research Centre, University of Oxford; D.E. Schlichting, RN, PhD, Eli Lilly and Co.; S.D. Beattie, PhD, Eli Lilly and Co.; M. Luchi, MD, FACR, MBA, Incyte Corp.; W. Macias, MD, PhD, Eli Lilly and Co.
- Address correspondence to Dr. C. Peterfy, Spire Sciences Inc., 5314 Boca Marina Circle N, Boca Raton, Florida 33487, USA. E-mail: charles.peterfy{at}spiresciences.com